News and Publications

Press Kit: Radiation Oncology Alternative Payment Model (RO-Model)

On July 10, 2019, the Centers for Medicare and Medicaid Services (CMS) proposed an advanced alternative payment model (RO-Model) for radiation oncology. ASTRO's official response and related materials are available below, and physician experts are available for interviews on request.


Press Materials

Official Statements

Background and Related Information

  • Video: Understanding the Radiation Oncology Alternative Payment Model, Anne Hubbard with Imaging Technology News, 9/20/19
  • Editorial: Radiation Oncology APM: Why us? Why now?, by Dr. Brian Kavanagh, 7/11/19
  • Op-Ed: Why Radiation Oncology Needs an APM, by Anne Hubbard for OncLive, 11/3/17
  • Previous statement: Response to HHS Secretary Azar’s comments on a radiation oncology alternative payment model, 11/8/18
  • Infographic: Radiation oncologists are ready to participate in an advanced alternative payment model
  • Blog post: RO-APM: What we know, what we don’t and what it all means, 2/14/19
  • Blog post: MIPS scores have radiation oncology asking, that's it?, 8/8/18
  • Radiation Oncology Alternative Payment Model (RO-APM) proposed by ASTRO, 4/27/17

External: Resources from CMS

  • Overview: Radiation Oncology Model, 7/10/19
  • Fact Sheet: Proposed Radiation Oncology (RO) Model, 7/10/19
  • Proposed Rule: Medicare Program; Specialty Care Models to Improve Quality of Care and Reduce Expenditures, 7/10/19
  • Report to Congress: Episodic Alternative Payment Model for Radiation Therapy Services, 11/17

Contacts and Social Media

Direct questions and interview requests to ASTRO’s media relations team. You can also reach us by phone at 703-286-1600. 

To keep up with the conversation on prior authorization, follow ASTRO on social media:

We have recently updated our privacy policy and terms of use.
By using this site, you agree to ASTRO’s Privacy Policy and Terms of Use.
We use cookies to provide, secure and improve our services to you. To learn more, click here.